Dr Hoenle AG (XTER:HNL) Cash And Cash Equivalents : €8.9 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Dr Hoenle AG Cash And Cash Equivalents?

Dr Hoenle AG's quarterly cash and cash equivalents declined from Sep. 2023 (€9.32 Mil) to Dec. 2023 (€8.55 Mil) but then increased from Dec. 2023 (€8.55 Mil) to Mar. 2024 (€8.92 Mil).

Dr Hoenle AG's annual cash and cash equivalents declined from Sep. 2021 (€12.07 Mil) to Sep. 2022 (€7.13 Mil) but then increased from Sep. 2022 (€7.13 Mil) to Sep. 2023 (€9.32 Mil).

Dr Hoenle AG Cash And Cash Equivalents Historical Data

The historical data trend for Dr Hoenle AG's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Hoenle AG Cash And Cash Equivalents Chart

Dr Hoenle AG Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Cash And Cash Equivalents

Get a 7-Day Free Trial

14.58

34.18

12.07

7.13

9.32

Dr Hoenle AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															6.76	6.95	9.32	8.55	8.92

Dr Hoenle AG Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Dr Hoenle AG (XTER:HNL) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Dr Hoenle AG Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Dr Hoenle AG's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Hoenle AG (XTER:HNL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Dr Hoenle AG (XTER:HNL) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

HNL:Germany HNL:Germany

Address

Nicolaus-Otto-Street 2, Gilching, Munich, BY, DEU, 82205

Website

https://www.hoenle.de

Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Equipment and Systems segment, which accounts for the majority of revenue, includes devices for UVC air and surface disinfection, and it is used for drying inks and coatings, for curing adhesives and plastics, and for solar simulation. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium?pressure and low-pressure lamps. Adhesives segment, which includes industrial adhesives designed for a broad spectrum of applications such as electronics, medical technology, optics, and glass processing. The company generates the majority of its revenue from sales in other countries.

Dr Hoenle AG (XTER:HNL) Headlines

No Headlines